AI assistant
BIOLIFE SOLUTIONS INC — Director's Dealing 2021
Nov 16, 2021
32106_dirs_2021-11-15_e451170a-6548-45c3-bcf1-23ff8195ca9e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: BIOLIFE SOLUTIONS INC (BLFS)
CIK: 0000834365
Period of Report: 2021-11-04
Reporting Person: Wichterman Troy (Chief Financial Officer)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1286 | Direct |
| Common Stock | 127 | Direct |
| Common Stock | 728 | Direct |
| Common Stock | 14644 | Direct |
| Common Stock | 5680 | Direct |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Employee Stock Option | $2.0600 | 2025-05-04 | Common Stock (938) | Direct |
Footnotes
F1: Restricted stock award granted pursuant to the BioLife Solutions 2013 Performance Incentive Plan (the "Plan") and vests in equal quarterly installments.
F2: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F3: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F4: Restricted stock award granted pursuant to the Plan and vests in equal quarterly installments.
F5: On May 4, 2015, the reporting person was granted an option to purchase 5,000 shares of common stock which vested in full on May 4, 2019 and of which 4,062 of such options have been exercised.